(As of November 1, 2011)
| Company Name |
RaQualia Pharma Inc. |
| Address |
5-2 Taketoyo, Aichi 470-2341 Japan |
| Business Summary |
RaQualia Pharma Inc. engages in the discovery, development, and marketing of clinical and preclinical candidates for human patients worldwide. |
| Establishment |
February 19, 2008 |
| Capital Fund |
8.48 billion yen |
| Employees |
81 |
| President & CEO |
Atsushi Nagahisa |
| Board of Directors |
- Representative Director
- Atsushi Nagahisa
- Director
- Susumu Tsuchiya
- Director
- Naoki Tani
- Director
- Shinichi Koizumi
- Director
- Akimitsu Hirai
|
| Statutory Auditor |
- Statutory Auditor
- Hisaharu Inoue
- Statutory Auditor
- Yasushi Honma
- Statutory Auditor
- Hisaji Agata
|
| Management |
- Senior Vice President
- Susumu Tsuchiya
- Senior Vice President
- Naoki Tani
- Senior Vice President
- Shinichi Koizumi
- Senior Vice President
- Akihiro Furuta
- Senior Vice President
- Tomoko Nii
- Vice President
- Sanshiro Horii
- Vice President
- Taisuke Inagaki
- Vice President
- Kazuhiro Ikeda
- Vice President
- Kiichiro Kawada
|
